Website Under Maintenance

Newsroom Published Jun 08, 2024 01:50 PM

Our site is down for scheduled maintenance. We are working to update our network to better provide the page you requested. We understand the inconvenience this may cause, but rest assured, we are doing everything we can to bring the site back online after our necessary updates.

Gossamer Bio to Present at Upcoming Investor Conferences

By: Gossamer Bio, Inc. via Business Wire

August 29, 2025 at 07:31 AM EDT

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Company will present at the following investor conferences in September.

Cantor Global Healthcare Conference

Date / Time:	September 3rd, at 9:10 AM ET
Format:	Fireside Chat & 1x1’s
Location:	New York, NY
Webcast Link:	https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=93028624&checkCompany=1&checkEmail=1&checkName=1

Wells Fargo Healthcare Conference

Date / Time:	September 4th
Format:	1x1’s
Location:	Boston, MA

H.C. Wainwright 27th Annual Global Healthcare

Date / Time:	September 9th, at 8:00 AM ET
Format:	Fireside Chat & 1x1’s
Location:	New York, NY

About Gossamer Bio

Gossamer Bio is a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Its goal is to be an industry leader in, and to enhance the lives of patients living with, pulmonary hypertension.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250829692001/en/

Contacts

For Investors and Media

Bryan Giraudo, Chief Operating Officer and Chief Financial Officer

Gossamer Bio Investor Relations

ir@gossamerbio.com

Website Under Maintenance

Website Under Maintenance

Gossamer Bio to Present at Upcoming Investor Conferences

Contacts

More News